Candriam Luxembourg S.C.A. »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2024-03-31 $702k 600 1169.30
2023-12-31 $612k 600 1019.27

More positions owned by Candriam Luxembourg S.C.A.

Vipshop Hldgs Sponsored Ads A (Principal) (VIPS)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Visa Com Cl A (V)
Regeneron Pharmaceuticals (REGN)
Amgen (AMGN)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
salesforce (CRM)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1